The Methodist Hospital System
The Methodist Hospital System. Leading Medicine

Methodist DeBakey Cardiology Associates

John J. Mahmarian, M.D., FACC, FASNC, FSCCT

Professor of Medicine, Weill Cornell Medical College

Dr. John J Mahmarian

Practice Location

Methodist DeBakey Cardiology Associates
Smith Tower
6550 Fannin, Suite 1901
Houston, TX 77030
713-441-1100

 

Medical School

New York Medical College, Valhalla, New York

Medicine Residency

Baylor College of Medicine, Houston, Texas

Cardiology Fellowship

Baylor College of Medicine, Houston, Texas

Areas of Interest

  • Nuclear Cardiology

Board Certification

  • Cardiovascular Disease
  • Subspecialty certification in Nuclear Cardiology and Cardiovascular Computed Tomography

Languages

English

Biography

Dr. John J. Mahmarian, director of the nuclear cardiology and computed tomography (CT) services at the Methodist DeBakey Heart and Vascular Center in Houston, is recognized nationally and internationally as an authority in nuclear cardiology and cardiac CT imaging. He balances his time between research and an active clinical practice.

Dr. Mahmarian's research addresses how to tailor therapy, reduce healthcare costs and improve treatment of heart disease using nuclear imaging, including myocardial perfusion imaging, cardiac CT, hybrid imaging and calcium scoring. He has written extensively on myocardial perfusion imaging, and CT angiography. His clinical focus is on prevention of heart disease, acute coronary syndromes and myocardial infarction.

After receiving his BS degree from Duke University, Dr. Mahmarian earned his MD degree from New York Medical College in Valhalla, New York. He did post graduate training at Baylor College of Medicine, where he served as chief medical resident. After completing his cardiology fellowship at Baylor, he was invited to join the faculty and subsequently rose to the rank of professor of medicine. Dr. Mahmarian is currently a professor of medicine at Weill Cornell Medical College. He is board-certified in cardiovascular disease with subspecialty certification in nuclear cardiology and cardiovascular computed tomography.

He is regularly invited to speak at national and international conferences, reviews manuscripts for peer-reviewed journals, and grades abstracts submitted to national scientific meetings. He is a fellow of the American College of Cardiology (ACC) and of the American Society of Nuclear Cardiology. He is currently Secretary for the Board of Directors of the American Society of Nuclear Cardiology, and has served as Nuclear Case Studies Team Leader of the ACC Cardiosource Editorial Board and as a member of the Certification Board of Nuclear Cardiology.

He recently spearheaded a multicenter study of stable patients post MI (the INSPIRE trial) looking at a new application for nuclear cardiac imaging and he is currently participating in several multicenter clinical research studies investigating new imaging agents.